Project Grant R01DK135668
Award Date
8/5/24
Completion Date
5/31/27
Dollars Obligated
$604K
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
This federal Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to evaluate the efficacy and safety of a proteolytic activity-guided fecal microbiota transplantation (FMT) approach for treating irritable bowel syndrome (IBS), particularly the post-infection subset (PI-IBS). The $316,102 award, effective September 1, 2024, will support a...
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a 5-year, $196,940 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The grant will fund a pilot randomized controlled trial to examine the feasibility, acceptability, and preliminary efficacy of a phone-based positive psychology intervention for patients with...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,941,591 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Connecticut. The goal of this 5-year grant, awarded on August 1, 2024, is to develop an objective, integrated multimodal electrophysiological (OIME) index to quantify visceral pain in patients with irritable bowel syndrome (IBS). The research will leverage wearable...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to advance the understanding of sensory neuron-mast cell interactions in the pathophysiology of irritable bowel syndrome (IBS). The $117,000 award, effective from June 15, 2025 to May 31, 2027, will fund research conducted by the Regents of the University of Michigan to investigate...
This $430,707 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will fund research to investigate autonomic nervous system (ANS) reactivity and personalized therapies for disorders of gut-brain interaction (DGBI) in children. The research team at the Medical College of Wisconsin, Inc. will develop an ANS-sensing system to measure vagal efficiency, a dynamic indicator...
This federal Project Grant award of $1,428,890, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA Program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, aims to evaluate the efficacy of a virtually delivered, heart rate variability (HRV) biofeedback-enhanced coping skills treatment program for adolescents aged 13-18 diagnosed with inflammatory bowel disease (IBD) and symptoms of anxiety or depression. The research team...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $273,000.00 to support research into the role of nociceptor sensory neurons and neuropeptides in regulating intestinal inflammation and tissue protection in inflammatory bowel diseases (IBD). The research aims to thoroughly investigate the neuro-immune-microbiota interactions that...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), totals $352,125 and is focused on evaluating heart rate variability (HRV) as a biomarker for clinical symptoms and psychological functioning in pediatric patients with inflammatory bowel disease (IBD). The award will support a study to: 1) determine the relationship between baseline HRV...
This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to investigate the role of impaired cellular RNA editing as a cause of inflammation in inflammatory bowel disease (IBD). The $858,460 award to The Leland Stanford Junior University will fund a 3-year research project to: 1) leverage genetic data to prioritize long...
This Project Grant award of $332,350.00, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to investigate the mechanisms of mechanosensation and inflammation-induced hypersensitivity in dorsal root ganglion (DRG) sensory neurons that innervate the colon. The research, led by the Principal Investigator at Harvard Medical School, aims to: 1)...